Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Biotechnology

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting more effective oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its primary research programs are the investigation of optimal formulations of DehydraTECH-enhanced glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drugs as well as the investigation of cannabidiol (CBD) for the reduction of hypertension leading to a cleared IND application by the United States Food and Drug Administration. It operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 46 patents granted and many patents pending worldwide.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp

Bullboard Posts

Comment by shawkon Dec 31, 2018 6:21pm

82 Views

Post# 29173660

RE:RE:Scam?

The connection to Lexaria was that Instadose was claiming to have a proprietary technology for infusing liquids and edibles with cannabis oil, making them a potential competitor to LXRP. There's no sign of them holding any patents or any large amount of oil.
As for APHA, the regulators in Canada and the US are closing in. The management siphoned 250 million from APHA into their own jeans and now they're making a bogus takeover offer through Green Growth, a company that APHA has financed with 25 million. These guys are going to jail!

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal